{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:14:54Z","timestamp":1761894894811,"version":"3.44.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004948","name":"Astellas Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004948","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.urology.2009.02.053","type":"journal-article","created":{"date-parts":[[2009,5,10]],"date-time":"2009-05-10T04:16:34Z","timestamp":1241928994000},"page":"944-950","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Efficacy of Bacille Calmette-Gu\u00e9rin Immunotherapy Predicted by Expression of Antigen-presenting Molecules and Chemokines"],"prefix":"10.1016","volume":"74","author":[{"given":"Paula A.","family":"Videira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando M.","family":"Calais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuela","family":"Correia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D\u00e1rio","family":"Ligeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9lio J.","family":"Crespo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Calais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9lder","family":"Trindade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2009.02.053_bib1","first-page":"17","article-title":"Intravesical chemotherapy versus immunotherapy for superficial bladder cancer","volume":"14","author":"Huben","year":"1996","journal-title":"Semin Urol Oncol"},{"key":"10.1016\/j.urology.2009.02.053_bib2","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0022-5347(17)58737-6","article-title":"Intracavitary bacillus Calmette-Gu\u00e9rin in the treatment of superficial bladder tumors","volume":"116","author":"Morales","year":"1996","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2009.02.053_bib3","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1097\/01.ju.0000073852.24341.4a","article-title":"Immune mechanisms in bacillus Calmette-Gu\u00e9rin immunotherapy for superficial bladder cancer","volume":"170","author":"Bohle","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2009.02.053_bib4","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S0022-5347(05)68633-8","article-title":"Bacillus-Calmette-Gu\u00e9rin (BCG) and 3D tumors: an in vitro model for the study of adhesion and invasion","volume":"162","author":"Durek","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2009.02.053_bib5","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/sj.bjc.6602026","article-title":"Role of urothelial cells in BCG immunotherapy for superficial bladder cancer","volume":"91","author":"Bevers","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.urology.2009.02.053_bib6","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1111\/j.1464-410X.2004.05176.x","article-title":"Urine dendritic cells: a noninvasive probe for immune activity in bladder cancer?","volume":"94","author":"Beatty","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2009.02.053_bib7","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.0818-9641.2004.01258.x","article-title":"The third way: progress on pathways of antigen processing and presentation by CD1","volume":"82","author":"Lawton","year":"2004","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.urology.2009.02.053_bib8","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S0090-4295(98)00188-5","article-title":"Intravesical bacille Calmette-Gu\u00e9rin induces the antiangiogenic chemokine interferon-inducible protein 10","volume":"52","author":"Poppas","year":"1998","journal-title":"Urology"},{"key":"10.1016\/j.urology.2009.02.053_bib9","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.semcancer.2003.10.001","article-title":"Chemokines in the recruitment and shaping of the leukocyte infiltrate of tumors","volume":"14","author":"Mantovani","year":"2004","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.urology.2009.02.053_bib10","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000115377","article-title":"Gene expression analysis in superficial bladder cancer: comparison of two suitable endogenous reference genes","volume":"1","author":"Videira","year":"2007","journal-title":"Curr Urol"},{"key":"10.1016\/j.urology.2009.02.053_bib11","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.urology.2009.02.053_bib12","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/nri2191","article-title":"CD1 antigen presentation: how it works","volume":"7","author":"Barral","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.urology.2009.02.053_bib13","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1126\/science.1115301","article-title":"Assistance of microbial glycolipid antigen processing by CD1e","volume":"310","author":"de la Salle","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.urology.2009.02.053_bib14","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1442-2042.2006.01697.x","article-title":"Bacillus Calmette-Gu\u00e9rin-pulsed dendritic cells stimulate natural killer T cells and gammadelta T cells","volume":"14","author":"Naoe","year":"2007","journal-title":"Int J Urol"},{"key":"10.1016\/j.urology.2009.02.053_bib15","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.4049\/jimmunol.175.3.1758","article-title":"Mycobacterium tuberculosis regulates CD1 antigen presentation pathways through TLR-2","volume":"175","author":"Roura-Mir","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.urology.2009.02.053_bib16","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1074\/jbc.M005652200","article-title":"The ligands of CXC chemokine receptor 3, I-TAC, MIG, and IP10, are natural antagonists for CCR3","volume":"276","author":"Loetscher","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.urology.2009.02.053_bib17","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1006\/bbrc.1995.1626","article-title":"Interferon gamma-inducible protein 10 (IP-10), a member of the CXC chemokine family, is an inhibitor of angiogenesis","volume":"210","author":"Strieter","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.urology.2009.02.053_bib18","doi-asserted-by":"crossref","first-page":"27348","DOI":"10.1074\/jbc.270.45.27348","article-title":"The functional role of the ELR motif in CXC chemokine-mediated angiogenesis","volume":"270","author":"Strieter","year":"1995","journal-title":"J Biol Chem"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429509003239?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429509003239?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T01:51:26Z","timestamp":1758765086000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429509003239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S0090429509003239"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2009.02.053","relation":{},"ISSN":["0090-4295"],"issn-type":[{"type":"print","value":"0090-4295"}],"subject":[],"published":{"date-parts":[[2009,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of Bacille Calmette-Gu\u00e9rin Immunotherapy Predicted by Expression of Antigen-presenting Molecules and Chemokines","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2009.02.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}